kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex KRAS mutation shown to promote
KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




